Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia

American Journal of Hematology

Volumn 77, Issue 4, 2004, Pages 391-396

  Wang, Sa ^a   Degar, Barbara A ^b   Zieske, Arthur ^a   Shafi, Nelofar Q ^c   Rose, Michal G ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

G CSF; GM CSF; Hemophagocytosis; Myelodysplasia; Splenectomy; Thrombophagocytosis

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; DISEASE EXACERBATION; DYSPNEA; ERYTHROPHAGOCYTOSIS; HUMAN; LEG EDEMA; LEUKOPENIA; MALE; MYELODYSPLASIA; NEUTROPENIA; PRIORITY JOURNAL; RECURRENT INFECTION; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

AGED; BLOOD CELL COUNT; BONE MARROW; FATAL OUTCOME; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; SPLENECTOMY; THROMBOCYTOPENIA;

EID: 9644270582     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20202     Document Type: Article

References (33)

1. Heaney, Mark L, Golde, David W. Medical progress: myelodysplasia. New Engl J Med 1999;340:1649-1960.
2. Kuyama J, Fushino M, Take H, Kanayama Y. Myelodysplastic syndrome associated with erythrophagocytosis by blasts and myeloid cells. Int J Hematol 1995;62:243-246.
3. Cohen AM, Alexandrova S, Bessler H, Mittelman M, Cycowitz Z, Djaldetti M. Ultrastructural observations on bone marrow cells of 26 patients with myelodysplastic syndromes. Leuk Lymphoma 1997;27:165-172.
4. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791-2808.
5. Negrin RS, Haeuber DH. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 1990;76:36-43.
6. Negrin RS, Stein R, Vardiman J, et al. Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 1993;82:737-743.
7. Hellstrom-Lindberg E, Ahlgren T, Beguin Y, et al. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood 1998;92:68-75.
8. Thompson JA, Gilliland DG, Prchal JT, et al. Effect of recombinant human erythropoietin combined with granulocyte/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study Group. Blood 2000;95:1175-1179.
9. Henter JI, Blinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
10. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78(11):2918-2922.
11. Egeler RM, Shapiro R, Loechelt B, Filipovich A. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 1996;18(4):340-345.
12. Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. Leukemia 1996;10:197.
13. Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001;114:761-769.
14. Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet 2001;68:590-597.
15. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957-1959.
16. McClain K, Gehrz R, Grierson H, et al. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am J Pediatr Hematol Oncol 1988;10:196-205.
17. Risdall RJ, Brunning RD, Hernandez JI, Gordon DH. Bacteria-associated hemophagocytic syndrome. Cancer 1984;54:2968-2972.
18. Wong KF, Hui PK, Chan JK, et al. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387-390.
19. Miyahara M, Sano M, Shibata K, et al. B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol 2000;79:378-388.
20. Gori-Bergamini Z, Spremolla G. Erythrophagocytosis in acute myeloblastic leukaemia: a morphological and ultrastructural study. Haematologica 1979;64:597-610.
21. Stark B, Resnitzky P, Jeison M, et al. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13) - case report and review of the literature. Leuk Res. 1995;19(6):367-379.
22. Imashuku S, Hibi S, Sako M, et al. Hemophagocytosis by leukemic blasts in 7 acute myeloid leukemia cases with t(16;21)(p11;q22): common morphologic characteristics for this type of leukemia. Cancer 2000;88:1970-1975.
23. Coulthard S, Chase A, Orchard K, et al. Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant. Br J Haematol 1998;100:561-553.
24. Mori H, Tawara M, Yoshida Y, et al. Minimally differentiated acute myeloid leukemia (AML-MO) with extensive erythrophagocytosis and del(20)(q11) chromosome abnormality. Leuk Res 2000;24:87-90.
25. Hassinger SL, Schiffer CA, Sun CC. Acute myeloblastic leukemia with extensive erythrophagocytosis mimicking malignant histiocytosis. Am J Clin Pathol 1989;92:696-700.
26. Cottle TE, Fier CJ, Donadieu J, Kinsey SE. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Semin Hematol 2002;39:134-140.
27. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1999;163:579-583.
28. Lee JC, Tripathy K. Neutrophilic thrombophagocytosis. Arch Pathol Lab Med 2000;124:1545-1546.
29. Delmer A, Karmochkine M, Cadiou M, Gerhartz H, Zittoun R. Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome. Am J Hematol 1990;34(1):73-74.
30. Wilson PA, Ayscue LH, Jones GR, Bentley SA. Bone marrow histiocytic proliferation in association with colony-stimulating factor therapy [comment]. Am J Clin Pathol 1993;99(3): 311-313.
31. Kraus MD, Bartlett NL, Fleming MD, Dorfman DM. Splenic pathology in myelodysplasia: a report of 13 cases with clinical correlation. Am J Surg Pathol 1998;22:1255-1266.
32. Tsuda H, Shirono K. Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor. Br J Haematol 1996;93(3):572-575.
33. Quesnel B, Catteau B, Aznar V, Bauters F, Fenaux P. Successful treatment of juvenile rheumatoid arthritis associated haemophagocytic syndrome by cyclosporin A with transient exacerbation by conventional-dose G-CSF. Br J Haematol 1997;97(2): 508-510.